News Releases

May 07, 2020
Sangamo Therapeutics Announces Virtual Format for 2020 Annual Meeting
BRISBANE, Calif. --(BUSINESS WIRE)--May 7, 2020-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that it is changing its 2020 Annual Meeting of Stockholders to a virtual-only format due to public health and safety concerns related to the coronavirus
Additional Formats
PDF Version
Apr 09, 2020
Sangamo Announces Closing of Biogen Collaboration Agreement
- Sangamo has received $225 million in stock proceeds; will receive additional $125 million upfront license fee by May 8, 2020 BRISBANE, Calif. --(BUSINESS WIRE)--Apr. 9, 2020-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the closing of its previously
Additional Formats
PDF Version
Displaying 1 - 10 of 15